Healthcare Professionals
Please log in for special information and services
Jaroslaw Marcoll Country Manager Poland

“AOP Orphan focuses on supporting the needs of the most vulnerable, often forgotten groups of patients - those with rare diseases. At AOP Orphan, we not only enable access to rare disease therapies, but also provide our competencies to support the entire treatment process.”

Jacek Kalinowski Marketing & Field Force Manager

“It is our privilege to cooperate with outstanding specialists and to support them to the best of our abilities in order to help patients with rare disorders.”

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Polish health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Poland occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2002 and this is where AOP Orphan also has one of its biggest local teams of around fifteen employees in the Marketing & Sales, and Medical for all three therapeutic divisions.

 

2mio
people
PATIENTS WITH RARE DISEASES IN poland
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. The problem of rare diseases in Poland pertains to over 2 million of citizens.
AVAILABLE TREATMENTS
In Poland AOP Orphan provides seven products. 
7
products
3
areas
THREE THERAPEUTIC AREAS
AOP Orphan Poland covers three area of treatments: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders.

Vision & Mission

Milestones